ERBB2 and triple-negative breast carcinoma: However, there is another group of triple-negative breast cancer (TNBC) patients that lack the expression of ER, PR (PRGR; Progesterone receptor), and HER-2 (ERBB2; Receptor tyrosine-protein kinase erbB-2) receptors.